Cutting it a bit fine, but it's that time again: The Spike's review of the year in neuroscience 2023: A Review of the Year in Neuroscience link.medium.com/7lJ0d4aTWFb Enjoy! including Dud{man,Lab}🇺🇦 @Datta_Lab @NicTritsch Jesse Goldberg Wei Ji Ma and many more

i think about this daily. evolution is sick

Had so much fun showing peter hess around the @Datta_Lab ✨ a wonderful primer on ML-guided phenotyping of animal behavior! 🦾

The genetic treatment targeted a particular kind of congenital deafness and will soon be tried in children who are younger. nyti.ms/3UcssS2

So cool to see Flagship Pioneering CEO Noubar Afeyan taking the stage at graduation at my alma mater 🦫

You call it the systems biology department, but to me it’ll always be

got y’all FOOLED 😤😂🧠

This is phenomenal work out of Figure x Open AI. The future is unstoppable 🚀

YES YOU GO BEST FRIEND 💥🌟

6 years and a lifetime of memories! ♥️ thanks for the ride Program in Neuroscience at Harvard Medical School

Happy to see my thesis work out today in nature! nature.com/articles/s4158… Josh Merel Jesse Marshall lhq Yuval Tassa Ugne Klibaite Amanda Gellis Greg Wayne Matt Botvinick @BOlveczky Google DeepMind Video credit to the talented Kristian J Herrera

Welcome aboard Andrew Beam! We're just getting started 🚀

Moo Deng is leaving OpenAI

That was fast!!

Today we introduce human neural loop #assembloids created from 4 parts derived from stem cells to study the cortico-striato-midbrain-thalamo-cortical pathway and to model neurodevelopmental disease Work led by the remarkable Ji-Il Kim and Yuki Miura in the lab. Also in

A study in nature presents a drug delivery system inspired by the ink-jet propulsion mechanisms of cephalopods, such as squid and cuttlefish. The approach could circumvent the need for needles to administer some types of medication and vaccines. go.nature.com/3UVOcRx

If you're coming to #NeurIPS2024, this won't be an event you'll want to miss! RSVP below 👇 Meet Lila Sciences 🚀

Johnny Yu, Nima Alidoust, Kevan Shokat, and I are excited to announce a historic achievement by our team at Vevo Therapeutics: Tahoe-100M, a 100M single-cell transcriptomic atlas, measuring how thousands of drugs impact cells from 50 diverse cancer lines. prnewswire.com/news-releases/…

I'm representing Lila at GTC today from 2p-7p. Stop by our booth and chat about autonomous science!

it has become in vogue to say ‘protein binder generation models dont actually matter all that much, bc optimizing binding is one of the easiest and least costly steps in the drug design process’ but the argument against that (which i increasingly believe!) is that drug